share_log

EF Hutton Initiates Coverage On Coeptis Therapeutics With Buy Rating, Announces Price Target of $6

EF Hutton Initiates Coverage On Coeptis Therapeutics With Buy Rating, Announces Price Target of $6

EF 赫頓以買入評級啟動 Coeptis 治療藥物的覆蓋範圍,宣布目標價格為 6 美元
Benzinga Real-time News ·  2022/12/13 06:38

EF Hutton analyst Michael King initiates coverage on Coeptis Therapeutics (NASDAQ:COEP) with a Buy rating and announces Price Target of $6.

EF Hutton分析師Michael King以買入評級啟動Coeptis治療公司(納斯達克:COEP)的報道,並宣佈目標價為6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論